» Articles » PMID: 15598661

Lipid Infusion Decreases the Expression of Nuclear Encoded Mitochondrial Genes and Increases the Expression of Extracellular Matrix Genes in Human Skeletal Muscle

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Dec 16
PMID 15598661
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

The association between elevated plasma free fatty acid (FFA) concentrations and insulin resistance is well known. Although the cause and effect relationship between FFAs and insulin resistance is complex, plasma FFA is negatively correlated with the expression of peroxisome proliferator activated receptor-gamma cofactor-1 (PGC-1) and nuclear encoded mitochondrial genes. To test whether this association is causal, we infused a triglyceride emulsion (or saline as control) into healthy subjects to increase plasma FFA for 48 h followed by muscle biopsies, microarray analysis, quantitative real time PCR, and immunoblots. Lipid infusion increased plasma FFA concentration from 0.48 +/- 0.02 to 1.73 +/- 0.43 mm and decreased insulin-stimulated glucose disposal from 8.82 +/- 0.69 to 6.67 +/- 0.66 mg/kg.min, both with p < 0.05. PGC-1 mRNA, along with mRNAs for a number of nuclear encoded mitochondrial genes, were reduced by lipid infusion (p < 0.05). Microarray analysis also revealed that lipid infusion caused a significant overexpression of extracellular matrix genes and connective tissue growth factor. Quantitative reverse transcription PCR showed that the mRNA expression of collagens and multiple extracellular matrix genes was higher after the lipid infusion (p < 0.05). Immunoblot analysis revealed that lipid infusion also increased the expression of collagens and the connective tissue growth factor protein. These data suggest that an experimental increase in FFAs decreases the expression of PGC-1 and nuclear encoded mitochondrial genes and also increases the expression of extracellular matrix genes in a manner reminiscent of inflammation.

Citing Articles

Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved.

Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .

PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.


Bioenergetic adaptations of small intestinal epithelial cells reduce cell differentiation enhancing intestinal permeability in obese mice.

Guerbette T, Ciesielski V, Brien M, Catheline D, Viel R, Bostoen M Mol Metab. 2025; 92:102098.

PMID: 39814101 PMC: 11795564. DOI: 10.1016/j.molmet.2025.102098.


Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity.

Martin S, Connor T, Sanigorski A, McEwen K, Henstridge D, Nijagal B Cell Death Dis. 2023; 14(12):787.

PMID: 38040704 PMC: 10692215. DOI: 10.1038/s41419-023-06319-5.


Extracellular matrix remodelling in obesity and metabolic disorders.

Musale V, Wasserman D, Kang L Life Metab. 2023; 2(4.

PMID: 37383542 PMC: 10299575. DOI: 10.1093/lifemeta/load021.


From Obesity-Induced Low-Grade Inflammation to Lipotoxicity and Mitochondrial Dysfunction: Altered Multi-Crosstalk between Adipose Tissue and Metabolically Active Organs.

Cavaliere G, Cimmino F, Trinchese G, Catapano A, Petrella L, DAngelo M Antioxidants (Basel). 2023; 12(6).

PMID: 37371902 PMC: 10295335. DOI: 10.3390/antiox12061172.